Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Comparative Effectiveness Research|May 22, 2024
Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionalsMaher S Moazin, Abdulaziz Baazeem, Ayman Al-Bakri, et al.
Frontiers in Nutrition|June 30, 2022
The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern VersionOsama Hamdy, Saud Al Sifri, Mohamed Hassanein, et al.
Diabetes Care|June 29, 2021
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled TrialJulio Rosenstock, Rifat Emral, Leobardo Sauque-Reyna, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trialRory J McCrimmon, Saud Al Sifri, Rifat Emral, et al.
Diabetes Research and Clinical Practice|April 25, 2020
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADANMohamed Hassanein, Saud Al Sifri, Shehla Shaikh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 13, 2021
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on SulfonylureasYousef Al-Saleh, Shaun Sabico, Ahmed Al-Furqani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 11, 2021
Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADANMohamed Hassanein, Saud Al Sifri, Shehla Shaikh, et al.
Frontiers in Endocrinology|January 28, 2026
Use of continuous glucose monitoring in non-intensively managed type 2 diabetes: a Saudi Arabian consensusMohammed Almehthel, Abdulghani Al-Saeed, Fahad Al-Sabaan, et al.
BMC Cardiovascular Disorders|May 15, 2026
Risk prediction and prevention in patients with advanced subclinical atherosclerosisMichael J Blaha, Abdulhalim J Kinsara, Abdulla Shehab, et al.
Saudi Medical Journal|July 4, 2018
Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi ArabiaSaud Al Sifri, Owayed Al Shammeri, Saleh Al Jaser, et al.
Pageof 3